Search

Now showing items 1-4 of 4

Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples

Cohen, CR; Lingappa, JR; Baeten, JM; Ngayo, MO; Spiegel, CA; Hong, T; Donnell, D; Celum, C; Kapiga, S; Delany, S; Bukusi, EA (2012)

Bacterial vaginosis (BV), a disruption of the normal vaginal flora, has been associated with a 60% increased risk of HIV-1 acquisition in women and higher concentration of HIV-1 RNA in the genital tract of HIV-1-infected ...

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.

Baeten, JM; Donnell, D; Mugo, NR; Ndase, P; Thomas, K; Campbell, J; Wangisi, J; Tappero, JW; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Tumwesigye, E; Were, E; Fife, KH; Kiarie, J; Farquhar, C; John-Stewart, G; Kidoguchi, L; Coombs, RW; Hendrix, C; Marzinke, MA; Frenkel, L; Haberer, JE; Bangsberg, D; Celum, C (2014)

Abstract BACKGROUND: Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious ...

Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.

Baeten, JM; Celum, C; Kiarie, J; Mujugira, A; Were, E; Mugo, NR; Donnell, D; Bukusi, EA; Ronald, A; Heffron, R; Murnane, PM (University of Nairobi, 2014)

BACKGROUND: For women at risk of HIV-1, effective contraception and effective HIV-1 prevention are global priorities. METHODOLOGY: In a clinical trial of pre-exposure prophylaxis (PrEP) for HIV-1 prevention in ...

Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.

Heffron, R; Mugo, N; Were, E; Kiarie, J; Bukusi, EA; Mujugira, A; Frenkel, LM; Donnell, D; Ronald, A; Celum, C; Baeten, JM (2014)

OBJECTIVE:: To evaluate preexposure prophylaxis (PrEP) efficacy for HIV-1 prevention among women using depot medroxyprogesterone acetate (DMPA) for contraception and men whose HIV-1-infected partners use DMPA. DESIGN ...